Bexarotene bulk supplier for pharma manufacturers

Bexarotene 75 mg Suppliers & Bulk Manufacturers

Available Forms: Capsules

Available Strengths: 75 mg

Reference Brands: Targretin (USA/EU)

Bexarotene is a retinoid X receptor (RXR) agonist used in the treatment of cutaneous T-cell lymphoma (CTCL), a type of skin cancer. It works by regulating the expression of genes that control cell growth, differentiation, and apoptosis (cell death), thereby slowing or stopping the growth of cancer cells.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description:

Bexarotene is an antineoplastic (anti-cancer) medicine sold under the brand name Targretin and is primarily used in the treatment of cutaneous T-cell lymphoma (CTCL), a rare type of non-Hodgkin lymphoma that mainly affects the skin. It belongs to the third generation of retinoids and works by selectively activating retinoid X receptors, which regulate gene expression involved in cell growth, differentiation, and programmed cell death. Through this targeted action, bexarotene helps slow the proliferation of malignant T-cells and reduces skin lesion severity.

Bexarotene is available in both systemic and topical forms. The oral form is indicated for patients with CTCL whose disease has not responded to at least one prior systemic therapy. The topical form is used for the treatment of skin lesions in patients with refractory or persistent CTCL, or in those who cannot tolerate other available treatments. Therapy with bexarotene requires medical supervision and regular monitoring, as it can affect lipid levels, thyroid function, and liver parameters. It is an important option in advanced or treatment-resistant CTCL management.

Bexarotene — third party manufacturing & bulk supply

Bexarotene 75 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Bexarotene is supplied as Capsules — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Bexarotene listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Bexarotene →

Back to Listing

Frequently Asked Questions

Bexarotene is used for the treatment of cutaneous T-cell lymphoma (CTCL), a rare type of non-Hodgkin lymphoma that affects the skin, especially in patients whose disease has not responded to other therapies. It helps slow or stop the growth of cancer cells by regulating gene expression involved in cell differentiation and proliferation.

Bexarotene is made from the active pharmaceutical ingredient bexarotene, which is a synthetic retinoid and belongs to a class of medicines known as retinoid X receptor (RXR) agonists.

The main trade name of bexarotene is Targretin.

The original brand Targretin was developed and marketed by Ligand Pharmaceuticals and later marketed by Eisai in several regions. Generic versions are also manufactured by other oncology-focused pharmaceutical companies.

The generic name is bexarotene.

The brand name is Targretin.

Bexarotene is manufactured in regulated pharmaceutical facilities across the USA, EU, UK, and other countries depending on the manufacturer and marketing authorization holder.